New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research uncovers mechanism behind stubborn memories

Research uncovers mechanism behind stubborn memories

BRAIN HEALTHMEDICAL SCIENCESMENTAL HEALTHNEUROSCIENCERESEARCH18 January 2024Researchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Depar
Breakthroughs March 11,2024
Research uncovers mechanism behind stubborn memories

Research uncovers mechanism behind stubborn memories

BRAIN HEALTHMEDICAL SCIENCESMENTAL HEALTHNEUROSCIENCERESEARCH18 January 2024Researchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Depar
Breakthroughs March 11,2024
New index to explore relationship between mental health and gender in adolescents in greater depth

New index to explore relationship between mental health and gender in adolescents in greater depth

by Juan Fernández González, Universitat Oberta de Catalunya (UOC)Credit: CC0 Public DomainHalf of mental health disorders first manifest themselves before the age of 14. Seventy percent appear before
Pediatrics March 11,2024
New index to explore relationship between mental health and gender in adolescents in greater depth

New index to explore relationship between mental health and gender in adolescents in greater depth

by Juan Fernández González, Universitat Oberta de Catalunya (UOC)Credit: CC0 Public DomainHalf of mental health disorders first manifest themselves before the age of 14. Seventy percent appear before
Pediatrics March 11,2024
Chronic Hepatitis B

Chronic Hepatitis B

RESEARCH29 January 2024New hepatitis B study reveals how viruses adapt to low-oxygen environments, such as those found deep within the liver, opening up possible new therapeutic targets for liver path
Breakthroughs March 11,2024
Chronic Hepatitis B

Chronic Hepatitis B

RESEARCH29 January 2024New hepatitis B study reveals how viruses adapt to low-oxygen environments, such as those found deep within the liver, opening up possible new therapeutic targets for liver path
Breakthroughs March 11,2024
Antipsychotics are increasingly being prescribed to children. Here's why we should be concerned

Antipsychotics are increasingly being prescribed to children. Here's why we should be concerned

by Matthias Pierce and Kathryn Abel,The ConversationPercentage of children prescribed antipsychotics, per year 2000 to 2019.Anincreasing numberof young people in the U.K. are being r
Pediatrics March 11,2024
Antipsychotics are increasingly being prescribed to children. Here's why we should be concerned

Antipsychotics are increasingly being prescribed to children. Here's why we should be concerned

by Matthias Pierce and Kathryn Abel,The ConversationPercentage of children prescribed antipsychotics, per year 2000 to 2019.Anincreasing numberof young people in the U.K. are being r
Pediatrics March 11,2024
New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)HEALTHMEDICAL SCIENCESMENTAL HEALTHRESEARCH29 January 2024Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Diso
Breakthroughs March 11,2024
New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)HEALTHMEDICAL SCIENCESMENTAL HEALTHRESEARCH29 January 2024Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Diso
Breakthroughs March 11,2024
'Help, my kids keep getting head lice!' Here's how to break the cycle of nits

'Help, my kids keep getting head lice!' Here's how to break the cycle of nits

by Cameron Webb,The ConversationHead lice have perfectly designed claws to scuttle up shafts of hai. Credit: A/Prof Webb/NSW Health PathologyWrangling head lice, and the children they infest, mu
Pediatrics March 11,2024
'Help, my kids keep getting head lice!' Here's how to break the cycle of nits

'Help, my kids keep getting head lice!' Here's how to break the cycle of nits

by Cameron Webb,The ConversationHead lice have perfectly designed claws to scuttle up shafts of hai. Credit: A/Prof Webb/NSW Health PathologyWrangling head lice, and the children they infest, mu
Pediatrics March 11,2024
Childhood lead exposure tied to worse cognitive function in late life

Childhood lead exposure tied to worse cognitive function in late life

Exposure to lead in childhood is associated with worse cognitive functioning in late life, according to a study published in the Nov. 11 issue ofScience Advances.Haena Lee, Ph.D., from Sungkyunk
Pediatrics March 11,2024
Childhood lead exposure tied to worse cognitive function in late life

Childhood lead exposure tied to worse cognitive function in late life

Exposure to lead in childhood is associated with worse cognitive functioning in late life, according to a study published in the Nov. 11 issue ofScience Advances.Haena Lee, Ph.D., from Sungkyunk
Pediatrics March 11,2024
Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

ARTIFICIAL INTELLIGENCEMEDICAL SCIENCESNEUROSCIENCERESEARCHSCIENCEResearchers from theMRC Brain Network Dynamics Unit and Oxford University’sDepartment of Computer Sciencehave set ou
Breakthroughs March 11,2024
Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

ARTIFICIAL INTELLIGENCEMEDICAL SCIENCESNEUROSCIENCERESEARCHSCIENCEResearchers from theMRC Brain Network Dynamics Unit and Oxford University’sDepartment of Computer Sciencehave set ou
Breakthroughs March 11,2024
Removing bias from healthcare AI tools

Removing bias from healthcare AI tools

22 February 2024Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate preexistin
Breakthroughs March 11,2024
Removing bias from healthcare AI tools

Removing bias from healthcare AI tools

22 February 2024Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate preexistin
Breakthroughs March 11,2024
Treatments compared for pediatric-onset multiple sclerosis

Treatments compared for pediatric-onset multiple sclerosis

More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon β-1a (IFNβ-1a) treatmen
Pediatrics March 11,2024
Treatments compared for pediatric-onset multiple sclerosis

Treatments compared for pediatric-onset multiple sclerosis

More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon β-1a (IFNβ-1a) treatmen
Pediatrics March 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com